GENERIS - FARMACEUTICA, S.A. secures contract for Acquisition Of Ketorolac 30 Mg/1 Ml Sol Inj Fr 1 Ml Im Iv Cpa 780/2024

Portugal, Nov. 6 -- Portugal based GENERIS - FARMACEUTICA, S.A. has secured contract from Unidade Local De Saude Do Alto Minho, Epe (Ulsam) for Acquisition Of Ketorolac 30 Mg/1 Ml Sol Inj Fr 1 Ml Im Iv Cpa 780/2024. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....